Novartis India Limited manufactures and sells healthcare products in India and internationally. It operates through four segments: Pharmaceuticals, Generics, Over-The-Counter, and Animal Health. The Pharmaceuticals segment offers a portfolio of prescription medicines in various therapeutic areas, including central nervous system, pain and inflammation, and transplantation/immunology through healthcare professionals primarily under the Voveran, Trioptal, Exelon, Tegrital, and Sandimmun Neoral brand names. This segment offers its products in various forms, such as tablets, capsules, liquid orals, injectables, creams and ointments, patches, and vials. The Generics segment offers retail generics products in various therapeutic areas, such as anti-TB, anti-DUB (gynecology), anti-histamines, antibiotics, anti-ulcerants, anti-diabetes, and cardiovascular. This segment offers its products in tablet and liquid-oral forms. The Over-The-Counter segment offers vitamins, minerals, and nutritional supplements, as well as products for the treatment of cough, cold, and allergy primarily under the Otrivin, Otrinoz, and T-minic brand names. It offers its products in various forms, which include powders-vitamin and nutritional supplements, tablets, capsules, and liquid-orals. The Animal Health segment offers drug formulations and feed supplements in cattle and poultry markets. The company was founded in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
novartis india ltd (HCBA:Mumbai)
Dr Annie Besant Road
Phone: 91 22 2495 8400
Fax: 91 22 2495 0221www.novartis.in/
|No competitor information is available for HCBA.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact NOVARTIS INDIA LTD, please visit www.novartis.in/. Company data is provided by Capital IQ. Please use this form to report any data issues.